| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.72B | 10.55B | 9.59B | 8.86B | 8.17B |
| Gross Profit | 3.60B | 3.54B | 3.18B | 2.88B | 2.38B |
| EBITDA | 2.15B | 2.15B | 1.90B | 1.64B | 697.68M |
| Net Income | 1.46B | 1.43B | 1.16B | 1.10B | 1.13B |
Balance Sheet | |||||
| Total Assets | 4.46B | 4.71B | 3.54B | 4.62B | 3.42B |
| Cash, Cash Equivalents and Short-Term Investments | 1.43B | 1.83B | 828.37M | 39.39M | 468.96M |
| Total Debt | 302.72M | 102.89M | 0.00 | 0.00 | 10.32M |
| Total Liabilities | 1.65B | 1.31B | 1.28B | 1.23B | 1.02B |
| Stockholders Equity | 2.81B | 3.41B | 2.26B | 3.39B | 2.40B |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 1.27B | 819.23M | 1.04B | 455.15M |
| Operating Cash Flow | 0.00 | 1.37B | 1.15B | 1.24B | 587.77M |
| Investing Cash Flow | 0.00 | -180.24M | 1.92B | -1.54B | -1.15B |
| Financing Cash Flow | 0.00 | -187.01M | -2.29B | -126.32M | -26.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥23.81B | 16.06 | ― | 0.73% | 17.86% | 21.52% | |
74 Outperform | ¥26.98B | 11.13 | ― | 4.36% | 12.32% | 10.42% | |
74 Outperform | ¥56.74B | 34.44 | ― | 2.74% | ― | ― | |
72 Outperform | ¥57.64B | 11.56 | 16.12% | 2.91% | 10.02% | 16.48% | |
65 Neutral | ¥30.97B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
46 Neutral | ¥93.03B | 15.20 | 2.57% | 1.97% | 19.61% | ― |
Mamezo Co., Ltd. reported a significant increase in its financial performance for the six months ending September 30, 2025, with net sales and profits showing notable year-on-year growth. The company plans to merge its three wholly-owned subsidiaries and transition to non-consolidated financial statements, which is expected to impact its future financial reporting and operations.